Tricycloundecane compounds useful as modulators of nuclear...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S101000

Reexamination Certificate

active

07550458

ABSTRACT:
Tricycloundecanes compounds, methods of using such compounds in the treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders, and pharmaceutical compositions containing such compounds are disclosed.

REFERENCES:
patent: 5387687 (1995-02-01), Scrima et al.
Brown, D. S. et al., “Ligand Effects in the Rhodium(II)-Catalyzed Reactions of α-Diazoamides”, J. Org. Chem., vol. 59, pp. 2447-2455 (1994).
Cartoon, M. E. K. et al., “Pyrazines. Part 5. Preparation of 3,8-Diazabicyclo[.2.1]octane-2,4-dione Derivatives”, J. Chem. Soc. Perkin I, vol. 7, pp. 1603-1606 (1980).
Tanaka, T. et al., “Oxidation of 2,6-Piperazinediones”, Bulletin of the Chemical Society of Japan, vol. 50, No. 7, pp. 1821-1823 (1977).
Tanaka, T. et al., “Reaction of 1,4-disubstituted 2,6-piperazinediones with chloranil”, Nippon Kagaku Kaishi, vol. 9, pp. 1450-1453 (1976).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Tricycloundecane compounds useful as modulators of nuclear... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tricycloundecane compounds useful as modulators of nuclear..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricycloundecane compounds useful as modulators of nuclear... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4068493

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.